Unlike the speculative environment seen in many small- and mid-cap stocks, several of India’s largest and most established companies are now trading at valuations that are considerably easier to justify. The Nifty 50 closed at 24,090.85 on August 27, 2026, with a trailing price-to-earnings ratio of roughly 20.4 times. That is remarkably close to its long-term median P/E of approximately 20.9 rather than an obvious market-wide bubble valuation.

Yet looking only at the index valuation hides an important opportunity. Individual blue-chip valuations are widely dispersed. HDFC Bank trades near 14 times earnings. TCS and Infosys are around 15 times. ITC is near 17 times. ICICI Bank trades around 18 times. Reliance Industries is around 23 times. In contrast, companies such as Bharti Airtel and Sun Pharma command substantially higher multiples because investors are assigning greater value to their growth prospects.

For investors with a five-to-ten-year horizon, September 2026 therefore appears less about predicting where the Nifty will move next month and more about identifying businesses capable of compounding earnings, cash flows and intrinsic value for many years.

This article analyses 10 Indian blue-chip stocks worth researching for long-term investment in September 2026, based on business quality, competitive advantage, latest earnings, sector outlook, valuation and risk.

Why Blue-Chip Stocks Matter for Long-Term Investors

The term blue chip usually refers to large, established companies with strong brands, substantial market share, experienced management, access to capital and a long operating history.

Blue chips are not risk-free. Their share prices can decline substantially during economic recessions, industry disruptions or periods of excessive valuation.

However, compared with smaller companies, established blue chips generally offer stronger balance sheets, greater liquidity, diversified revenue streams, easier access to financing, deeper institutional ownership, more extensive analyst coverage, stronger corporate governance systems and a better ability to survive economic downturns.

For investors trying to build wealth over decades rather than weeks, these characteristics are important. The objective should not simply be to find a stock that can rise quickly. The objective is to own businesses capable of increasing earnings per share over multiple economic cycles.

Indian Blue-Chip Market Snapshot Before September 2026

Market-price and valuation data are based on information available around August 27, 2026. Prices and multiples can change rapidly.

1. ICICI Bank — One of India’s Strongest Banking Compounding Stories

ICICI Bank deserves to be near the top of a September 2026 blue-chip research list. The transformation of ICICI Bank over the past several years has been substantial. Asset quality has strengthened, underwriting has improved, capital remains comfortable and profitability has become considerably more consistent.

Q1 FY27 continued that trend. Standalone profit after tax increased 15.9% year-on-year to ₹14,805 crore. The total loan portfolio expanded 19.6%, while deposits increased 14%. Gross non-performing assets declined to 1.38%, while net NPAs remained only 0.35%. The bank’s CET-1 capital ratio stood at 16.19%.

India remains structurally underpenetrated in mortgages, consumer finance, wealth management, insurance, SME credit and organised financial services. As household incomes increase, strong banks can capture more of these financial flows.

Main risks include a deterioration in credit quality, aggressive loan growth, interest-rate changes and an eventual increase in credit costs.

Research view: One of the strongest combinations of growth, asset quality and valuation among India’s blue chips.

2. Reliance Industries — India’s Diversified Digital, Consumer and Energy Giant

Reliance Industries is no longer simply an oil and petrochemicals company. It has gradually transformed into a diversified ecosystem spanning refining and petrochemicals, Reliance Retail, Jio telecommunications, digital platforms, media, consumer brands and new-energy investments.

Q1 FY27 demonstrated the strength of this diversification. Reliance reported gross revenue of approximately ₹3.40 lakh crore and EBITDA of ₹54,067 crore. Jio Platforms’ EBITDA increased approximately 15%, while ARPU reached ₹215.6. Oil-to-chemicals EBITDA rose 17.2%.

Very few companies anywhere in the world combine telecom, consumer retail, digital infrastructure and energy at Reliance’s scale. Jio gives Reliance exposure to India’s rising data consumption, retail captures household spending, traditional energy generates cash, and new-energy investments provide optionality.

Main risks are capital intensity, commodity volatility, pressure on retail profitability during expansion and execution risk in large new-energy projects.

Research view: A core long-term blue-chip candidate for diversified exposure to India’s consumer, technology and energy transformation.

3. Larsen & Toubro — A Direct Play on India’s Infrastructure Expansion

If India’s infrastructure and capital-expenditure cycle continues for another decade, Larsen & Toubro is one of the clearest large-cap beneficiaries. L&T operates across infrastructure, heavy engineering, energy, defence, technology and international projects.

Q1 FY27 consolidated revenue increased approximately 6.7% to ₹67,942 crore, while profit attributable to shareholders rose about 14%. Management retained its FY27 expectation of approximately 10–12% growth in both revenue and orders.

India requires enormous investment in highways, metros, railways, airports, renewable energy, power transmission, manufacturing facilities, defence infrastructure, data centres and water systems. L&T possesses engineering capability and project-execution expertise that smaller competitors often cannot match.

Main risks include project delays, commodity inflation, margin pressure, international exposure and geopolitical risk.

Research view: Among the strongest structural blue-chip plays on India’s infrastructure and manufacturing development.

4. Mahindra & Mahindra — Growth Inside an Old-Economy Company

Mahindra & Mahindra has evolved into one of India’s most interesting large-cap growth businesses. Its traditional tractor franchise remains dominant, while the SUV business has grown rapidly and electric vehicles create another possible growth engine.

Q1 FY27 consolidated revenue rose 28% to ₹58,188 crore, while consolidated PAT increased 34% to ₹5,455 crore. The company reported an annualised consolidated ROE of approximately 23%.

Mahindra held roughly 25% SUV revenue market share, 44.9% tractor market share, 52% share in sub-3.5-tonne LCVs and 39.5% share in electric three-wheelers.

Rising rural incomes can help tractors, increasing household wealth supports SUVs, urban logistics supports commercial vehicles and EV adoption offers another growth platform.

Main risks include auto cyclicality, commodity prices and increasing competition in SUVs and EVs.

Research view: One of the most attractive blue-chip growth-and-valuation combinations entering September 2026.

5. TCS — A High-Quality IT Giant at a Lower Valuation

Indian IT services have experienced a painful valuation reset amid concerns over weak discretionary spending, immigration costs and artificial intelligence potentially reducing conventional software-development work.

TCS trades at approximately 15 times earnings, far below the premium valuations historically associated with the company. Q1 FY27 revenue grew 2.7% year-on-year in US dollars, while operating margin stood at 24%.

More importantly, TCS reported US$9.5 billion in total contract value, while its AI-related annualised revenue run rate reached US$2.6 billion, up 13.6% sequentially.

AI may reduce some traditional coding revenue, but it also creates demand for cloud modernisation, data architecture, cybersecurity, AI implementation and autonomous business processes.

Research view: A contrarian blue-chip opportunity if high-quality Indian IT services adapt successfully to AI.

6. Infosys — Attractive Valuation With Better Recent Growth

Infosys presents a similar opportunity. Its shares have corrected substantially and currently trade around 14–15 times earnings.

Q1 FY27 revenue increased 14% year-on-year to ₹48,211 crore. Operating profit increased 15.4%, while net profit rose 12.2% to ₹7,769 crore. Operating margin stood at 21.1%.

At today’s valuation, investors are no longer required to assume extraordinary growth. Even moderate growth combined with dividends and share repurchases can produce reasonable long-term returns if earnings remain resilient.

The main risk is AI-driven structural disruption to conventional IT-services economics.

Research view: One of the more compelling value-oriented large-cap technology opportunities, but investors must accept AI-related uncertainty.

7. Bharti Airtel — A Powerful Telecom Compounder, but Valuation Matters

Bharti Airtel has emerged from years of brutal telecom competition as one of India’s strongest communications businesses.

Q1 FY27 consolidated revenue increased 18.4% to ₹58,539 crore, while reported net profit increased roughly 37% to ₹8,167 crore. Average revenue per user increased from ₹250 to ₹264, while the 4G and 5G customer base continued to expand.

Indian telecom has consolidated dramatically, reducing the probability of the irrational price competition seen in previous years. Increasing data consumption provides room for higher ARPU, while postpaid, broadband and enterprise services offer additional opportunities.

The principal issue is valuation: Bharti trades near 37.5 times earnings, meaning investors are already paying for substantial future growth.

Research view: Excellent business; less compelling valuation. Better accumulated during corrections than chased aggressively.

8. Sun Pharma — India’s Specialty Pharmaceutical Leader

Sun Pharmaceutical Industries has evolved from a conventional generic-drug manufacturer into a company with a growing global specialty portfolio.

Q1 FY27 revenue increased 10.5% to approximately ₹15,300 crore, while reported consolidated net profit rose roughly 27% to ₹2,895 crore. Specialty medicine sales increased 12.8% to approximately US$351 million and represented nearly 22% of total revenue.

Specialty pharmaceuticals can offer stronger margins and pricing power than commoditised generics. Sun’s strategy is therefore gradually changing the economics of the company.

Main risks include regulatory scrutiny, product concentration, acquisition integration and a valuation near 36 times earnings.

Research view: A high-quality defensive growth stock, but investors should demand sufficient valuation discipline.

9. ITC — A Value and Dividend Blue Chip

ITC has historically been viewed primarily as a cigarette business, but that description is increasingly incomplete. The company operates in cigarettes, packaged foods, personal care, paper and packaging, agricultural commodities and emerging digital and consumer businesses.

Its Q1 FY27 was complicated by tax increases and business disruptions, yet its non-cigarette FMCG segment delivered 12% revenue growth while segment profit increased 21%. Paperboard segment profit increased 38%.

The stock trades at about 17 times earnings with a dividend yield above 5% based on current market data. That produces an unusual combination of high cash generation, a large consumer franchise, relatively modest valuation and meaningful yield.

The main risk is continued dependence on cigarettes, including taxation and ESG-related ownership constraints.

Research view: One of the better defensive/value blue chips for investors prioritising cash flow and dividends over maximum growth.

10. HDFC Bank — Cheap Blue Chip, but September Requires Caution

Under ordinary circumstances, HDFC Bank would rank among India’s safest long-term banking franchises. Its scale, branch network, retail franchise and deposit base remain formidable.

Q1 FY27 standalone profit increased approximately 5% to ₹19,060 crore. However, the bank enters September 2026 with additional uncertainty after shares fell sharply amid concerns over a proposed US securities class-action lawsuit, earlier governance questions and leadership uncertainty. HDFC Bank has stated that the allegations are without merit and that it intends to defend itself.

At roughly 13.9 times earnings, HDFC Bank is one of the cheapest major private banks. But a falling share price is not automatically an opportunity. Investors must determine whether the issue affects the long-term franchise, management credibility or regulatory position.

Research view: Potentially attractive contrarian value, but September investors should monitor governance and leadership developments carefully.

Which Blue Chips Look Most Attractive for September 2026?

Strong Quality-Growth Candidates

• ICICI Bank — strong asset quality, excellent loan growth and healthy capital.
• Mahindra & Mahindra — outstanding momentum with a still-reasonable valuation.
• Reliance Industries — multiple structural growth drivers across telecom, retail and energy.
• Larsen & Toubro — powerful exposure to India’s long-term infrastructure and manufacturing investment cycle.

Value and Contrarian Opportunities

• TCS — substantial disruption is already reflected in the valuation.
• Infosys — stronger recent growth and a low historical multiple.
• ITC — high cash flow and dividends offer defensive support.
• HDFC Bank — valuation is attractive, but governance and leadership uncertainty requires caution.

Premium Growth Stocks

• Bharti Airtel — excellent operating trajectory but a higher earnings multiple.
• Sun Pharma — high-quality specialty-pharma exposure, with valuation and acquisition execution to monitor.

Why Buying Price Still Matters With Blue Chips

Many investors believe a blue-chip company can be purchased at any price because it will eventually recover. That is dangerous.

Consider a company earning ₹100 per share. At a 20× P/E, the share might trade at ₹2,000. At a 50× P/E, the same earnings justify a market price of ₹5,000. Even if earnings subsequently double to ₹200, the stock could still fall if investors eventually decide the fair valuation is only 20 times earnings: ₹200 × 20 = ₹4,000.

The business doubled its earnings, yet the investor who bought at ₹5,000 still lost money. That is why valuation matters even for exceptional businesses.

September 2026 is particularly interesting because valuations differ dramatically between sectors. Investors should avoid assuming all blue chips offer equivalent value.

How to Build a Long-Term Blue-Chip Portfolio

A portfolio should not simply contain ten famous companies. It should contain businesses with different economic drivers.

This reduces the risk that the entire portfolio depends on one economic theme. IT stocks may struggle when the US economy weakens. Banks may struggle during a credit cycle. Consumer companies may suffer from inflation. Infrastructure firms may face government-spending slowdowns. Healthcare can provide greater defensiveness.

Diversification works because different businesses respond differently to the same economic environment.

Should You Invest Everything in September?

Probably not. Even if a business appears attractive, predicting short-term share-price movements is extremely difficult.

Instead of committing the entire intended investment on September 1, a long-term investor could consider staggered accumulation: invest an initial portion, retain capital for corrections, review Q2 results when released, add when earnings support the thesis, and avoid chasing sudden rallies.

This approach reduces timing risk. It does not eliminate business risk. A declining stock should only be accumulated if the long-term investment thesis remains intact.

What Could Go Wrong With Indian Blue Chips?

Global recession: A major US or European slowdown would affect Indian IT exports and potentially global capital flows.

Oil prices: India imports most of its crude oil. Elevated energy prices can increase inflation and hurt the rupee and corporate margins.

Geopolitical conflict: Reliance, L&T and many other companies have direct or indirect exposure to global trade and the Middle East.

Interest rates: Rates affect banks, automobile financing, housing and overall market valuations.

AI disruption: TCS and Infosys face perhaps the most important technological transition in the history of Indian IT outsourcing.

Regulatory changes: Banks, telecom, pharmaceuticals and tobacco businesses are all heavily regulated.

Excessive valuations: A strong company can still deliver weak stock returns if the starting valuation is too high.

Final September 2026 Research View

If the objective is long-term wealth creation rather than short-term speculation, the most interesting Indian blue chips entering September 2026 can be divided into three categories.

Best balance of growth and fundamentals: ICICI Bank, Mahindra & Mahindra, Reliance Industries and Larsen & Toubro.

Best valuation opportunities: TCS, Infosys and ITC.

Quality businesses where entry price matters: Bharti Airtel and Sun Pharma.

Contrarian candidate requiring additional monitoring: HDFC Bank. The low valuation is tempting, but current governance, legal and leadership developments should be watched carefully before treating the decline as an automatic buying opportunity.

Conclusion: Blue Chips Can Still Create Wealth—If Bought With Discipline

Investing in Indian blue-chip stocks in September 2026 should not be about predicting whether the Sensex or Nifty will rise next month. Long-term investing operates on a completely different time scale.

The relevant questions are whether India’s banking system will be substantially larger in 2035, whether Indians will consume more mobile data, whether India will build more infrastructure, whether household spending and vehicle ownership will grow, whether companies will continue investing in digital transformation, whether demand for medicines will expand, and whether India will manufacture more goods domestically.

If the answer to most of these questions is yes, high-quality companies positioned around those trends should have opportunities to grow considerably over the next decade.

But investors must remember one fundamental principle: a great company becomes a great investment only when the price paid allows investors to participate in its future growth.

For September 2026, ICICI Bank, Reliance Industries, Larsen & Toubro and Mahindra & Mahindra stand out for their combination of scale, competitive position and structural growth. TCS and Infosys deserve renewed attention after the major correction in IT valuations. ITC offers a compelling combination of cash generation, dividends and valuation. Bharti Airtel and Sun Pharma remain excellent businesses, although their higher multiples require stronger future earnings. HDFC Bank may ultimately become one of the more interesting contrarian opportunities, but governance and leadership questions should be better understood before investors rely purely on its inexpensive valuation.

The best strategy is therefore not to buy every blue chip at once. Build a watchlist, determine reasonable valuation ranges, invest gradually, read quarterly results, watch cash flows and balance sheets, and give good businesses enough time to compound.

Over a decade, consistent compounding from high-quality businesses purchased at sensible valuations remains one of the most powerful mechanisms for long-term wealth creation in the Indian equity market.

Selected Sources

• Nifty 50 and company valuation data — Screener.in, accessed around August 27, 2026.
• ICICI Bank Q1 FY27 Performance Review — ICICI Bank.
• Reliance Industries Q1 FY27 financial reporting — Reliance Industries.
• Larsen & Toubro Q1 FY27 results and guidance — company/Reuters reporting.
• Mahindra & Mahindra Q1 FY27 results — Mahindra & Mahindra.
• TCS Q1 FY27 financial results — Tata Consultancy Services.
• Infosys Q1 FY27 results — Infosys.
• Bharti Airtel Q1 FY27 results — company/Reuters reporting.
• Sun Pharma Q1 FY27 results — company/Reuters reporting.
• ITC Q1 FY27 media statement — ITC.
• HDFC Bank Q1 FY27 results and August 2026 governance/legal developments — company/Reuters reporting.

Disclaimer: This article is provided solely for educational and informational purposes. It is not personalised financial advice, an investment recommendation or an offer to buy or sell securities. Equity investments are subject to market risk. Market prices and valuation multiples are based primarily on information available on August 27, 2026 and may change materially. Investors should verify the latest NSE/BSE filings and consult a SEBI-registered investment adviser where appropriate.